Chromosomal breakage in Crohn's disease: Anticlastogenic effect of D-penicillamine and L-cysteine
β Scribed by I. Emerit; J. Emerit; A. Levy; M. Keck
- Publisher
- Springer
- Year
- 1979
- Tongue
- English
- Weight
- 363 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
β¦ Synopsis
The incidence of chromosome breakage was found to be elevated in 42 patients with Crohn's disease. This phenomenon was much more striking in cultures set up with TCM 199 than in cultures set up with RPMI 1629 rich in L-cysteine. The drug D-penicillamine, a close analog of L-cysteine, gave an apparent therapeutic response in several patients and reduced the chromosome breakage frequency in the lymphocytes of these patients in vitro and in vivo.
π SIMILAR VOLUMES
Background: Vitamin D is essential for osteopenia therapy in Crohn's disease (CD). The active form of vitamin-D (aVD) is the 1,25(OH)2D. There are no data available whether aVD or plain vitamin-D (pVD) has any advantage in managing osteoporosis in CD or has any effect on the activity of the disease
Background: Genome-wide microarray expression analysis creates a comprehensive picture of gene expression at the cellular level. The aim of this study was to investigate differential intestinal gene expression in patients with Crohn's disease (CD) and controls with subanalysis of confirmed CD suscep
## Abstract Individuals with Parkinson's disease show dramatic improvements in their ability to move when medicated. However, the neural cause of this improvement is unclear. One hypothesis is that neural activation patterns, as measured by surface electromyography (EMG), are normalized by medicati
Author roles: Conception and design (Espay, Lang, Chen), data acquisition (Espay, Chen), drafting (Espay), editing and revising of the text (Lang, Chen).